loading

Nuvectis Pharma Inc Azioni (NVCT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
37.63%
2.66
4.265 4.486 4.262 2.367
Operating Income/Loss
35.97%
-4.396
-6.866 -6.158 -5.772 -4.101
Income/Loss From Continuing Operations Before Tax
37.01%
-4.171
-6.622 -5.881 -5.708 -4.049
Income/Loss From Continuing Operations After Tax
37.01%
-4.171
-6.622 -5.881 -5.708 -4.049
Net Income/Loss
37.01%
-4.171
-6.622 -5.881 -5.708 -4.049
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7,603%
16.56
0.215 16.10 15.18 14.72
Diluted Average Shares
7,603%
16.56
0.215 16.10 15.18 14.72
Basic Earnings Per Share
39.02%
-0.25
-0.41 -0.37 -0.38 -0.27
Diluted Earnings Per Share
39.02%
-0.25
-0.41 -0.37 -0.38 -0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.39
price down icon 0.34%
$36.24
price down icon 0.27%
$23.15
price up icon 7.69%
$96.83
price down icon 0.40%
$108.13
price up icon 0.15%
biotechnology ONC
$247.47
price up icon 1.13%
Capitalizzazione:     |  Volume (24 ore):